Patents Assigned to BioVision A/S
  • Survivin-derived peptides and use thereof
    Publication number: 20040176573
    Abstract: MHC Class I-restricted peptides derived from the tumor associated antigen, survivin, which peptides are capable of binding to Class I HLA molecules at a high affinity, capable of eliciting INF-&ggr;-producing cells in a PBL population of a cancer patient and capable of in situ detection of cytotoxic T cells in a tumor tissue, therapeutic and diagnostic composition comprising the peptide and uses hereof.
    Type: Application
    Filed: November 19, 2003
    Publication date: September 9, 2004
    Applicant: BioVision A/S
    Inventors: Eivind Per Thor, Mads Hald